La Jolla Pharmaceutical Company To Acquire Tetraphase Pharmaceuticals June 24 (Reuters) - Tetraphase Pharmaceuticals Inc: LA JOLLA
On closing, La Jolla will become a wholly owned subsidiary of Innoviva, and shares of La Jolla s common stock will no longer be listed on any public market. The transaction was unanimously approved by the La Jolla and Innoviva boards of directors and is expected to close within 30 business days.
Innoviva Specialty Therapeutics integrates Entasis Therapeutics Holdings Inc. (Entasis), a pioneer in the development of novel, anti-infective therapies, and La Jolla Pharmaceutical Company (La Jolla), with proven capabilities in commercializing medicines in critical care and hospital settings.
Contacts buyeszopiclonetabletonline.simplybook.me Buy Eszopiclone Tablet Online, 1030 Torrey Pines Rd La Jolla, 1030 Torrey Pines Rd La Jolla.
La Jolla Pharmaceutical Company. La Jolla Pharmaceutical Company is dedicated to the commercialization of innovative therapies that improve outcomes in patients
About La Jolla Pharmaceutical Company. La Jolla Pharmaceutical Company is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering
About La Jolla Pharmaceutical Company. La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for
LA JOLLA PHARMACEUTICAL : Chardan Suspends Coverage on La Jolla Pharmaceutical at Buy Rating With $15 Price Target : MT LA JOLLA PHARMACEUTICAL : Chardan Adjusts La Jolla Pharmaceutical's Price Target to $15 From $20, Keeps at Buy : MT
La Jolla Pharma (LJPC) advanced chart and technical analysis tool allows you to add studies and indicators such as Moving Averages (SMA and EMA), MACD
Comments
Thanks and keep writing
⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️